Pharmena S.a.
$3.19▲ 0.31%(+$0.01)
TickerSpark Score
48/100
▌ Weak
55
Valuation
25
Profitability
55
Growth
76
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHR.WA research report →
52-Week Range38% of range
Low
$2.50
Current
$3.19
High
$4.32
Company Overviewwww.pharmena.eu
About the company
Pharmena S. A. engages in the sale of dietary supplements in Poland and internationally.
- CEO
- Konrad Palka
- IPO
- 2010
- Employees
- 7
- HQ
- Lódz, LDZ, PL
Price Chart
-8.07% · this period
Valuation
- Market Cap
- $35.53M
- P/E
- -12.67
- P/S
- 22.14
- P/B
- 3.88
- EV/EBITDA
- -12.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 18.38%
- Op Margin
- -197.20%
- Net Margin
- -172.02%
- ROE
- -27.21%
- ROIC
- -33.17%
Growth & Income
- Revenue
- $1.58M · 488.43%
- Net Income
- $-2,769,000 · -119.41%
- EPS
- $-0.25 · -127.27%
- Op Income
- $-3,281,000
- FCF YoY
- -9.26%
Performance & Tape
- 52W High
- $4.32
- 52W Low
- $2.50
- 50D MA
- $3.31
- 200D MA
- $3.37
- Beta
- 0.63
- Avg Volume
- 2.91K
Get TickerSpark's AI analysis on PHR.WA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · PHR.WA
Our PHR.WA coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on PHR.WA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHR.WA report →Internal Compare
Similar companies
Peers in the same neighborhood.